|
|
|
| Webinar: A CCS is a purpose-built machine, not a black box: Understand the workings | Discover how to transform your contamination control strategy from a static compliance document into a dynamic, data-driven system. In this CAI webinar, learn how to connect operational evidence, monitoring data, and risk assessments to drive continuous improvement, strengthen contamination control decisions, and maintain a defensible CCS throughout its lifecycle while fostering a proactive quality culture. Click here to learn more. |
|
|
|
|
|
| Tablet Edge Erosion – Solutions For Friability | Article | Natoli Engineering Company, Inc. | Addressing tablet edge erosion and friability involves adjusting formulation, tablet design, tooling, press setup, and operation speed to improve tablet robustness and reduce weight loss. |
|
|
|
|
By Katie Anderson, Chief Editor, Pharmaceutical Online | In a Pharmaceutical Online Live discussion on building inspection-ready systems with digital documentation, panelists emphasized that AI can accelerate review, trend analysis, and inspection response, but only when governed, validated, and kept firmly under human quality oversight. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
|
| Scaling Digital Logbooks In Pharmaceutical Manufacturing | Article | By Nishika Makwana, Tulip | Digital logbooks often fail to scale due to validation burden. Gain insight into how a structured, governed approach enables compliant digitization across sites, without revalidating every form. |
|
|
| Enhancing Biopharmaceutical Production Through Advanced Mixing | White Paper | By Paulo Bento and Scott Patterson, ILC Dover, An Ingersoll Rand Business | Eliminate particulate contamination and product degradation in downstream bioprocessing. Find out how frictionless, levitating impeller technology ensures low-shear mixing and high yields. |
|
|
|
|
|
|
| Small Joint Implants: A New Era With Medureon™ Bionate | Article | dsm-firmenich | Advances in biomaterials address challenges of small joint implants, improving durability, flexibility, and biocompatibility to reduce wear, enhance motion, and support long‑term patient outcomes. |
|
|
|
|
| Don't Let Seals Break Your Batch: A Risk-Based Approach | Article | Asahi Kasei Bioprocess | Optimize biopharmaceutical manufacturing by implementing risk-based seal maintenance. Tailor replacement protocols using data and advanced monitoring for enhanced efficiency and compliance. |
|
|
|
| Safely Scaling High Potency API Manufacturing | White Paper | Recipharm | Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up. |
|
|
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|